<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Nystatin - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Nystatin</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Derm / ENT / Eye / Topicals</div>
      <h1>Nystatin</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Nystatin 100,000 units/mL Suspension 100mL</li>
          <li>Nystatin 100,000 units/g Cream</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Oral candidiasis (thrush)</strong>
            <ul>
              <li>Suspension: 4–6 mL (400,000–600,000 units) swish and swallow 4 times daily</li>
              <li>Continue for at least 48 hours after symptoms resolve (typically 7–14 days total)</li>
            </ul>
          </li>
          <li><strong>Cutaneous/intertriginous candidiasis</strong>
            <ul>
              <li>Cream: Apply thin layer to affected area 2–3 times daily</li>
              <li>Continue for 7–14 days or until lesions have resolved</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Treatment of oropharyngeal candidiasis (oral thrush)</li>
          <li>Treatment of cutaneous and mucocutaneous candidal infections (skin folds, groin, axillae)</li>
          <li>Topical treatment of superficial Candida infections</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to nystatin or any component of the formulation</li>
          <li>Not for systemic fungal infections (not absorbed orally)</li>
          <li>Oral suspension contains sucrose; consider in diabetic patients</li>
          <li>Pregnancy/lactation: Generally considered safe for topical use; oral suspension use acceptable when indicated</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Oral: GI upset (nausea, diarrhea), unpleasant taste</li>
          <li>Topical: Local irritation, contact dermatitis (uncommon)</li>
          <li>Hypersensitivity reactions (rare)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li><strong>Oral suspension:</strong> Shake well before use; swish in mouth as long as possible before swallowing (or spit if instructed)</li>
          <li>Administer after meals or at least 30 minutes before eating when possible to maximize contact time</li>
          <li>For denture wearers: remove dentures during treatment and soak/clean dentures separately</li>
          <li><strong>Topical cream:</strong> Clean and dry affected area before application; wash hands before and after use</li>
          <li>Avoid occlusive dressings unless directed</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response: resolution of white patches (oral), erythema/scaling (skin) within 48–72 hours</li>
          <li>If no improvement after 7 days or worsening symptoms, reassess diagnosis (possible resistant organism or non-candidal etiology)</li>
          <li>For cutaneous infections: monitor for secondary bacterial infection</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Confirm diagnosis when feasible (oral thrush: white plaques that scrape off leaving red base)</li>
          <li>Consider predisposing factors: antibiotic use, inhaled corticosteroids, immunosuppression, diabetes, dentures</li>
          <li>If recurrent or refractory cases: consider systemic antifungal need and medical consultation/evacuation planning</li>
          <li>Document treatment response to guide duration and need for escalation</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (nystatin oral suspension): <a href="https://pdf.hres.ca/dpd_pm/00068640.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00068640.PDF</a></li>
          <li>Health Canada product monograph (nystatin topical cream): <a href="https://pdf.hres.ca/dpd_pm/00068641.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00068641.PDF</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
